138 related articles for article (PubMed ID: 36595382)
1. Early-stage glottic cancer of rare squamous cell carcinoma variants: a population-based study.
Takenaka Y; Uno A; Tanaka H; Takemoto N; Inohara H
Acta Otolaryngol; 2023 Jan; 143(1):70-76. PubMed ID: 36595382
[TBL] [Abstract][Full Text] [Related]
2. Sinonasal squamous cell carcinoma and the prognostic implications of its histologic variants: a population-based study.
Vazquez A; Khan MN; Blake DM; Patel TD; Baredes S; Eloy JA
Int Forum Allergy Rhinol; 2015 Jan; 5(1):85-91. PubMed ID: 25278180
[TBL] [Abstract][Full Text] [Related]
3. Basaloid squamous cell carcinoma of the larynx: analysis of 145 cases with comparison to conventional squamous cell carcinoma.
Fritsch VA; Lentsch EJ
Head Neck; 2014 Feb; 36(2):164-70. PubMed ID: 23765951
[TBL] [Abstract][Full Text] [Related]
4. Distant metastasis in head and neck squamous cell carcinoma variants: A population-based study.
Takenaka Y; Uno A; Tanaka H; Takemoto N; Inohara H
Head Neck; 2023 Apr; 45(4):882-889. PubMed ID: 36811303
[TBL] [Abstract][Full Text] [Related]
5. Prognostic implications of pathologically determined tumour volume in glottic carcinomas treated by transoral laser microsurgery.
Wilkie MD; Lightbody KA; Pinto R; Tandon S; Jones TM; Lancaster J
Clin Otolaryngol; 2015 Dec; 40(6):610-5. PubMed ID: 25816841
[TBL] [Abstract][Full Text] [Related]
6. Management of T3N1 glottic carcinoma: therapeutic outcomes.
Spector JG; Sessions DG; Lenox J; Simpson J
Laryngoscope; 2006 Jan; 116(1):106-10. PubMed ID: 16481820
[TBL] [Abstract][Full Text] [Related]
7. The role of survivin expression in the differential diagnosis of laryngeal (glottic) verrucous squamous cell carcinoma.
Marioni G; Pillon M; Bertolin A; Staffieri A; Marino F
Eur J Surg Oncol; 2007 Mar; 33(2):229-33. PubMed ID: 17088041
[TBL] [Abstract][Full Text] [Related]
8. Early glottic cancer in a veteran population: Impact of race on management and outcomes.
Fullmer TM; Shi J; Skinner HD; Hernandez DJ; Huang AT; Mai W; Parke RB; Donovan DT; Sandulache VC
Laryngoscope; 2020 Jul; 130(7):1733-1739. PubMed ID: 31461171
[TBL] [Abstract][Full Text] [Related]
9. Prognostic significance of surgical margins after transoral laser microsurgery for early-stage glottic squamous cell carcinoma.
Jumaily M; Faraji F; Osazuwa-Peters N; Walker RJ; Ward GM
Oral Oncol; 2019 Oct; 97():105-111. PubMed ID: 31473467
[TBL] [Abstract][Full Text] [Related]
10. Matched-pair analysis of survival in patients with poorly differentiated versus well-differentiated glottic squamous cell carcinoma.
Chen P; Yu W; Huang J; Xu H; Li G; Chen X; Huang Z
Oncotarget; 2017 Feb; 8(9):14770-14776. PubMed ID: 28122353
[TBL] [Abstract][Full Text] [Related]
11. Primary surgery for advanced-stage laryngeal cancer: A stage and subsite-specific survival analysis.
Harris BN; Bhuskute AA; Rao S; Farwell DG; Bewley AF
Head Neck; 2016 Sep; 38(9):1380-6. PubMed ID: 27014858
[TBL] [Abstract][Full Text] [Related]
12. Survival Impact of Initial Therapy in Patients with T1-T2 Glottic Squamous Cell Carcinoma.
Brady JS; Marchiano E; Kam D; Baredes S; Eloy JA; Park RC
Otolaryngol Head Neck Surg; 2016 Aug; 155(2):257-64. PubMed ID: 27026735
[TBL] [Abstract][Full Text] [Related]
13. Definitive radiotherapy for early (T1-T2) glottic squamous cell carcinoma: a 20 year Cleveland Clinic experience.
Khan MK; Koyfman SA; Hunter GK; Reddy CA; Saxton JP
Radiat Oncol; 2012 Nov; 7():193. PubMed ID: 23164282
[TBL] [Abstract][Full Text] [Related]
14. Treatment results and prognostic factors for advanced squamous cell carcinoma of the larynx treated with concurrent chemoradiotherapy.
Taguchi T; Nishimura G; Takahashi M; Komatsu M; Sano D; Sakuma N; Arai Y; Yamashita Y; Shiono O; Hirama M; Sakuma Y; Ishitoya J; Hata M; Ogino I; Oridate N
Cancer Chemother Pharmacol; 2013 Oct; 72(4):837-43. PubMed ID: 23959463
[TBL] [Abstract][Full Text] [Related]
15. Surgical vs Nonsurgical Treatment Modalities for T3 Glottic Squamous Cell Carcinoma.
Al-Gilani M; Skillington SA; Kallogjeri D; Haughey B; Piccirillo JF
JAMA Otolaryngol Head Neck Surg; 2016 Oct; 142(10):940-946. PubMed ID: 27389641
[TBL] [Abstract][Full Text] [Related]
16. Management of stage IV glottic carcinoma: therapeutic outcomes.
Spector GJ; Sessions DG; Lenox J; Newland D; Simpson J; Haughey BH
Laryngoscope; 2004 Aug; 114(8):1438-46. PubMed ID: 15280724
[TBL] [Abstract][Full Text] [Related]
17. How phenotype guides management of non-conventional squamous cell carcinomas of the larynx?
López F; Williams MD; Cardesa A; Hunt JL; Strojan P; Rinaldo A; Nixon IJ; Rodrigo JP; Saba NF; Mendenhall WM; Quer M; Suárez C; Ferlito A
Eur Arch Otorhinolaryngol; 2017 Jul; 274(7):2709-2726. PubMed ID: 28364287
[TBL] [Abstract][Full Text] [Related]
18. Cancer of the larynx: the northern Alberta experience.
Marck PA; Lupin AJ
J Otolaryngol; 1989 Dec; 18(7):344-9. PubMed ID: 2593218
[TBL] [Abstract][Full Text] [Related]
19. Laryngeal Papillary Squamous Cell Carcinoma: A Population-Based Analysis of Incidence and Survival.
Dutta R; Husain Q; Kam D; Dubal PM; Baredes S; Eloy JA
Otolaryngol Head Neck Surg; 2015 Jul; 153(1):54-9. PubMed ID: 25917664
[TBL] [Abstract][Full Text] [Related]
20. Management of T3N0M0 glottic carcinoma: therapeutic outcomes.
Sessions DG; Lenox J; Spector GJ; Newland D; Simpson J; Haughey BH; Chao KS
Laryngoscope; 2002 Jul; 112(7 Pt 1):1281-8. PubMed ID: 12169914
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
